scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1090936411 |
P356 | DOI | 10.1245/S10434-017-5941-0 |
P698 | PubMed publication ID | 28766212 |
P50 | author | Carla S. Fisher | Q87139983 |
Brian Czerniecki | Q88334128 | ||
P2093 | author name string | Julia Tchou | |
Paul J Zhang | |||
Lucy M De La Cruz | |||
Kahyun Yoon-Flannery | |||
Joey Bahng | |||
Lauren M DeStefano | |||
Rose E Mustafa | |||
P2860 | cites work | Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysis | Q33243821 |
Early dissemination seeds metastasis in breast cancer | Q33562263 | ||
Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer | Q36955125 | ||
HER-2/neu overexpression as a predictor for the transition from in situ to invasive breast cancer | Q37270033 | ||
Expression of HER2neu in ductal carcinoma in situ is associated with local recurrence | Q37940691 | ||
Breast cancer statistics, 2015: Convergence of incidence rates between black and white women | Q40379855 | ||
Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ | Q41467413 | ||
HER2-positive status is an independent predictor for coexisting invasion of ductal carcinoma in situ of the breast presenting extensive DCIS component. | Q42480187 | ||
Risk of subsequent in situ and invasive breast cancer in human epidermal growth factor receptor 2-positive ductal carcinoma in situ. | Q50592584 | ||
P577 | publication date | 2017-08-01 | |
P1433 | published in | Annals of Surgical Oncology | Q2853069 |
P1476 | title | Evaluating the Risk of Upstaging HER2-Positive DCIS to Invasive Breast Cancer |
Q90275893 | A retrospective alternative for active surveillance trials for ductal carcinoma in situ of the breast |
Q90593569 | In Vitro Models for Studying Invasive Transitions of Ductal Carcinoma In Situ |
Q95857000 | Predictors for upstaging of ductal carcinoma in situ (DCIS) to invasive carcinoma in non-mass-type DCIS |
Q90394997 | Triple-negative and HER2 positive ductal carcinoma in situ of the breast: characteristics, behavior, and biomarker profile |
Search more.